Device
FIBRACOL™
FIBRACOL™ is a medical device with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Recruiting2
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
active_not_recruiting125%
recruiting250%
completed125%
Recent Activity
3 active trials
Showing 4 of 4
completednot_applicable
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT06403605
recruitingnot_applicable
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
NCT06767501
recruitingnot_applicable
Clinical Trial Evaluating an Amnion Membrane Allograft Intended for Use in the Management of Non- Healing Venous Leg Ulcers Versus Standard Of Care Alone
NCT06764953
active_not_recruitingnot_applicable
Omega3 Wound Fish Skin Graft in the Treatment of DFUs
NCT04133493
Clinical Trials (4)
Showing 4 of 4 trials
NCT06403605Not Applicable
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT06767501Not Applicable
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
NCT06764953Not Applicable
Clinical Trial Evaluating an Amnion Membrane Allograft Intended for Use in the Management of Non- Healing Venous Leg Ulcers Versus Standard Of Care Alone
NCT04133493Not Applicable
Omega3 Wound Fish Skin Graft in the Treatment of DFUs
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4